In the present study, we tested in vitro the effects of MARCKS inhibition by treating IBC vs. nIBC cells with MPS in terms of cell proliferation, migration and invasion, mammosphere formation, and signaling pathways. This evidence concerns the gene MARCKS and inflammatory breast carcinoma.